Dermapharm Holding SE (DMP) - Total Liabilities

Latest as of March 2026: €1.54 Billion EUR ≈ $1.80 Billion USD

Based on the latest financial reports, Dermapharm Holding SE (DMP) has total liabilities worth €1.54 Billion EUR (≈ $1.80 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Dermapharm Holding SE - Total Liabilities Trend (2013–2025)

This chart illustrates how Dermapharm Holding SE's total liabilities have evolved over time, based on quarterly financial data. See Dermapharm Holding SE short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Dermapharm Holding SE Competitors by Total Liabilities

The table below lists competitors of Dermapharm Holding SE ranked by their total liabilities.

Company	Country	Total Liabilities
CA Immobilien Anlagen AG VI:CAI	Austria	€2.89 Billion
HUISHANG BK CORP. H YC1 F:HB8	Germany	€2.09 Trillion
Foot Locker Inc NYSE:FL	USA	$3.93 Billion
Tokai Carbon Korea Co. Ltd KQ:064760	Korea	₩40.75 Billion
Six Flags Entertainment Corporation NYSE:FUN	USA	$7.19 Billion
Braze Inc NASDAQ:BRZE	USA	$438.89 Million
Embotelladora Andina S.A SN:ANDINA-B	Chile	CL$2.13 Trillion
West African Resources Limited F:W25	Germany	€957.40 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Dermapharm Holding SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Dermapharm Holding SE.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dermapharm Holding SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dermapharm Holding SE (2013–2025)

The table below shows the annual total liabilities of Dermapharm Holding SE from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€1.50 Billion ≈ $1.76 Billion	+2.12%
2024-12-31	€1.47 Billion ≈ $1.72 Billion	-8.91%
2023-12-31	€1.62 Billion ≈ $1.89 Billion	+83.52%
2022-12-31	€880.34 Million ≈ $1.03 Billion	-2.95%
2021-12-31	€907.13 Million ≈ $1.06 Billion	+0.81%
2020-12-31	€899.81 Million ≈ $1.05 Billion	+18.34%
2019-12-31	€760.38 Million ≈ $888.97 Million	+69.54%
2018-12-31	€448.50 Million ≈ $524.34 Million	+31.29%
2017-12-31	€341.62 Million ≈ $399.39 Million	+36.16%
2016-12-31	€250.89 Million ≈ $293.32 Million	-0.53%
2015-12-31	€252.22 Million ≈ $294.88 Million	-14.96%
2014-12-31	€296.59 Million ≈ $346.74 Million	-3.90%
2013-12-31	€308.62 Million ≈ $360.80 Million	--

About Dermapharm Holding SE

XETRA:DMP Germany Drug Manufacturers - Specialty & Generic

Market Cap

$2.82 Billion

€2.41 Billion EUR

Market Cap Rank

#5812 Global

#893 in Germany

Share Price

€48.65

Change (1 day)

+1.46%

52-Week Range

€32.05 - €51.80

All Time High

€80.48